✦ LIBER ✦

Baseline Low-Density Lipoprotein Cholesterol Is an Important Predictor of the Benefit of Intensive Lipid-Lowering Therapy: A PROVE IT–TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22) Analysis

✍ Scribed by Roberto R. Giraldez; Robert P. Giugliano; Satishkumar Mohanavelu; Sabina A. Murphy; Carolyn H. McCabe; Christopher P. Cannon; Eugene Braunwald

Book ID: 119267634
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 366 KB
Volume: 52
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2008.05.046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reduction in Recurrent Cardiovascular Ev

Reduction in Recurrent Cardiovascular Events With Intensive Lipid-Lowering Statin Therapy Compared With Moderate Lipid-Lowering Statin Therapy After Acute Coronary Syndromes: From the PROVE IT–TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22) Trial

✍ Sabina A. Murphy; Christopher P. Cannon; Stephen D. Wiviott; Carolyn H. McCabe; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 227 KB

Improved outcome after acute coronary sy

Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) trial

✍ Jean Rouleau 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Effect of Intensive Statin Therapy on Cl

Effect of Intensive Statin Therapy on Clinical Outcomes Among Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome: PCI-PROVE IT: A PROVE IT–TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22) Substudy

✍ C. Michael Gibson; Yuri B. Pride; Claudia P. Hochberg; Sarah Sloan; Marc S. Saba 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Seasonal Variation in Lipids in Patients

Seasonal Variation in Lipids in Patients Following Acute Coronary Syndrome on Fixed Doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study)

✍ Patricia Tung; Stephen D. Wiviott; Christopher P. Cannon; Sabina A. Murphy; Caro 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 428 KB

Effect of statin dose on incidence of at

Effect of statin dose on incidence of atrial fibrillation: Data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis in Myocardial Infarction 22 (PROVE IT–TIMI 22) and Aggrastat to Zocor (A to Z) trials

✍ Dalton S. McLean; Shmuel Ravid; Michael Blazing; Bernard Gersh; Amy Shui; Christ 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Effect of Intensive Lipid-Lowering Thera

Effect of Intensive Lipid-Lowering Therapy on Mortality After Acute Coronary Syndrome (a Patient-Level Analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction 22 Trials)

✍ Sabina A. Murphy; Christopher P. Cannon; Stephen D. Wiviott; James A. de Lemos; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 256 KB